The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Hanim Sen
Showing 1-6 of 6 articles
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial
Tandjung K,
Lam MK,
Sen H,
de Man F,
Louwerenburg H,
Stoel M,
van Houwelingen K,
Linssen GCM,
van der Palen J,
Doggen CJM,
von Birgelen C
July 20, 2016 | 10.4244/EIJY15M08_01
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial
Lam MK,
Tandjung K,
Sen H,
Basalus M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
Linssen GCM,
Said S,
Nienhuis M,
de Man F,
van der Palen J,
von Birgelen C
June 19, 2015 | 10.4244/EIJV11I2A32
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial
Löwik M,
Lam MK,
Sen H,
Tandjung K,
van Houwelingen K,
de Man F,
Stoel M,
Louwerenburg H,
Linssen GCM,
Doggen CJM,
von Birgelen C
March 20, 2015 | 10.4244/EIJY14M08_11
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial
Sen H,
Lam MK,
Tandjung K,
Basalus M,
de Man F,
Louwerenburg H,
Stoel M,
van Houwelingen K,
Löwik M,
Linssen GCM,
Said S,
Nienhuis M,
Verhorst P,
van der Palen J,
von Birgelen C
October 20, 2014 | 10.4244/EIJV10I6A117
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents
Sen H,
Tandjung K,
Basalus M,
L M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
de Man F,
Linssen GCM,
Nijhuis R,
Nienhuis M,
Verhorst P,
van der Palen J,
von Birgelen C
October 26, 2012 | 10.4244/EIJV8I6A104
Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry
de Man F,
Tandjung K,
Hartmann M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
Basalus M,
Sen H,
Löwik M,
von Birgelen C
July 27, 2012 | 10.4244/EIJV8I3A52
1
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke